DK262584A - Interferon-gelformulering og fremgangsmaade til fremstilling heraf - Google Patents

Interferon-gelformulering og fremgangsmaade til fremstilling heraf Download PDF

Info

Publication number
DK262584A
DK262584A DK262584A DK262584A DK262584A DK 262584 A DK262584 A DK 262584A DK 262584 A DK262584 A DK 262584A DK 262584 A DK262584 A DK 262584A DK 262584 A DK262584 A DK 262584A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
gel formulation
interferon gel
interferon
Prior art date
Application number
DK262584A
Other languages
English (en)
Other versions
DK262584D0 (da
Inventor
Michael Anton Zupon
Joel August Sequeira
Alan Steven Kirschner
Pui-Ho Yuen
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK262584D0 publication Critical patent/DK262584D0/da
Publication of DK262584A publication Critical patent/DK262584A/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK262584A 1983-05-31 1984-05-28 Interferon-gelformulering og fremgangsmaade til fremstilling heraf DK262584A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/499,138 US4469228A (en) 1983-05-31 1983-05-31 Interferon kit

Publications (2)

Publication Number Publication Date
DK262584D0 DK262584D0 (da) 1984-05-28
DK262584A true DK262584A (da) 1984-12-01

Family

ID=23983998

Family Applications (1)

Application Number Title Priority Date Filing Date
DK262584A DK262584A (da) 1983-05-31 1984-05-28 Interferon-gelformulering og fremgangsmaade til fremstilling heraf

Country Status (12)

Country Link
US (1) US4469228A (da)
EP (1) EP0127130A3 (da)
JP (1) JPS6069036A (da)
AU (1) AU559039B2 (da)
CA (1) CA1218602A (da)
DK (1) DK262584A (da)
GB (1) GB2140690B (da)
HU (1) HUT34126A (da)
IL (1) IL71957A (da)
NZ (1) NZ208301A (da)
PT (1) PT78655B (da)
ZA (1) ZA844045B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284249A1 (en) * 1987-03-13 1988-09-28 Interferon Sciences, Inc. Lyophilized lymphokine composition
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
CA2137723C (en) * 1993-12-14 1996-11-26 Canon Kabushiki Kaisha Display apparatus
US6328987B1 (en) * 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon
US20020118595A1 (en) * 2001-02-26 2002-08-29 Miller Scott H. Enclosed implantable material mixing system
EA012205B1 (ru) * 2004-05-17 2009-08-28 Арес Трейдинг С.А. Гидрогелевые препараты интерферона
BRPI0510526A (pt) * 2004-06-01 2007-10-30 Ares Trading Sa formulações lìquidas estabilizadas de interferon
SI2234645T1 (sl) * 2007-12-20 2012-07-31 Merck Serono Sa Formulacije peg interferon beta

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2893547A (en) * 1957-05-01 1959-07-07 Fenwal Inc Kit and packaging, mixing and dispensing means for mixture ingredients
US3064802A (en) * 1960-07-25 1962-11-20 Fenwal Inc Kit and packaging, mixing and dispensing means for mixture ingredients
GB1057440A (en) * 1962-11-26 1967-02-01 Ghimas S A R L A method of keeping mutually incompatible substances within the same container
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US3616543A (en) * 1969-10-31 1971-11-02 Merck & Co Inc Method of producing a multicomponent lyophilized product
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4089432A (en) * 1977-05-06 1978-05-16 The Upjohn Company Vial and closure
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon
WO1983001198A1 (en) * 1981-10-08 1983-04-14 Kurt Frimann Berg Method and composition for treating a patient suffering from interferon-susceptible disorder
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation

Also Published As

Publication number Publication date
IL71957A (en) 1987-07-31
IL71957A0 (en) 1984-09-30
PT78655A (en) 1984-06-01
EP0127130A3 (en) 1986-07-02
ZA844045B (en) 1985-01-30
GB8413581D0 (en) 1984-07-04
GB2140690A (en) 1984-12-05
DK262584D0 (da) 1984-05-28
GB2140690B (en) 1986-11-19
CA1218602A (en) 1987-03-03
US4469228A (en) 1984-09-04
EP0127130A2 (en) 1984-12-05
AU2882384A (en) 1984-12-06
AU559039B2 (en) 1987-02-19
JPS6069036A (ja) 1985-04-19
PT78655B (en) 1986-08-08
NZ208301A (en) 1986-12-05
HUT34126A (en) 1985-02-28

Similar Documents

Publication Publication Date Title
DK211084D0 (da) Hurtigtoploesende laegemiddelpraeparater og fremgangsmaade til fremstilling heraf
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK565882A (da) Interferonpraeparater og fremgangsmaade til fremstilling heraf
DK493882A (da) Faeldningskiselsyre og fremgangsmaade til fremstilling deraf
DK493583D0 (da) Azolderivater og fremgangsmade til fremstilling deraf
DK298084D0 (da) Termistorer og fremgangsmaade til fremstilling deraf
DK256485A (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK112984A (da) Naphthalenyl- og tetrahydronaphthalenylimidazoler og fremgangsmaade til fremstilling deraf
DK130182A (da) Antagonister for argininvasopressin og fremgangsmaade til fremstilling heraf
DK276683A (da) Carbapenemer og fremgangsmaade til fremstilling deraf
DK262584A (da) Interferon-gelformulering og fremgangsmaade til fremstilling heraf
DK621484D0 (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK445784A (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK596784D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK343183D0 (da) Ketoquinoliner og fremgangsmade til fremstilling deraf
DK135684D0 (da) 2-cyano-imidazopyridin-derivater og fremgangsmaade til fremstilling heraf
DK38284A (da) N-(substitueret methyl)-azetidin-2-oner og fremgangsmaade til fremstilling heraf
DK26384D0 (da) Toxoplasmosefaktor og fremgangsmade til fremstilling deraf
DK454784A (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK454684A (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK552284D0 (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK90083D0 (da) Isoxazolopyrimidinderivater og fremgangsmade til fremstilling deraf
DK112682A (da) Azaspiroalkandioner og fremgangsmaade til fremstilling deraf
DK284184A (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment